Abscopal
Showing 1 - 25 of 166
Tumors, Secondary Malignant Tumor Trial (SBRT + LDRT, SBRT alone)
Not yet recruiting
- Neoplasms
- Secondary Malignant Neoplasm
- SBRT + LDRT
- SBRT alone
- (no location specified)
Nov 15, 2022
Tumors, Secondary Malignant Tumor Trial in Seoul (SBRT + LDRT)
Recruiting
- Neoplasms
- Secondary Malignant Neoplasm
- SBRT + LDRT
-
Seoul, Korea, Republic of
- +1 more
Feb 16, 2023
Thymoma Trial in Shanghai (Radiotherapy Combined with GM-CSF)
Recruiting
- Thymoma
- Radiotherapy Combined with GM-CSF
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jun 2, 2022
Radiation Effects on Bone
Enrolling by invitation
- Soft Tissue Sarcoma Adult
- Control Group
- +3 more
-
Syracuse, New YorkSUNY Upstate Medical University
Oct 31, 2022
Bystander Effect, Abscopal Effect, Unresectable Malignant Solid Tumor Trial in Klagenfurt (SBRT-PATHY (SBRT-based PArtial Tumor
Recruiting
- Bystander Effect
- +3 more
- SBRT-PATHY (SBRT-based PArtial Tumor irradiation targeting HYpoxic segment)
-
Klagenfurt, Kaernten, AustriaKABEG Klinikum Klagenfurt, Institute for Radiation Oncology
Apr 6, 2022
Non-Small-Cell Lung Cancer Stage IV Trial in Chongqing (Bevacizumab, Toripalimab, SBRT)
Recruiting
- Non-Small-Cell Lung Cancer Stage IV
- Bevacizumab
- +2 more
-
Chongqing, Chongqing, ChinaXinqiao Hospital of Chongqing
May 13, 2021
Solid Tumor, Lymphoma Trial in Beijing (Manganese Chloride, Radiotherapy, Chemo-immunotherapy)
Recruiting
- Solid Tumor
- Lymphoma
- Manganese Chloride
- +2 more
-
Beijing, Beijing, ChinaBiotherapeutic Department of Chinese PLA General Hospital
May 4, 2021
Melanoma Trial in France (Nivolumab + Ipilimumab, Combined treatment schema)
Terminated
- Melanoma
- Nivolumab + Ipilimumab
- Combined treatment schema
-
Bordeaux, France
- +5 more
Dec 3, 2020
Thymic Epithelial Tumor Trial in Shanghai (rhGM-CSF,Peginterferon alfa-b2,radiation)
Not yet recruiting
- Thymic Epithelial Tumor
- rhGM-CSF,Peginterferon alfa-b2,radiation
-
Shanghai, Shanghai, ChinaFudan University shanghai cancer center
Aug 16, 2020
Advanced Malignant Solid Tumor, Metastatic Malignant Tumor in the Liver, Metastatic Malignant Tumor in the Lung Trial in Houston
Not yet recruiting
- Advanced Malignant Solid Neoplasm
- +3 more
- Hafnium Oxide-containing Nanoparticles NBTXR3
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Feb 2, 2022
Hepatocellular Carcinoma Trial in Hong Kong (Durvalumab, Tremelimumab, Yttrium-90 radioembolisation)
Recruiting
- Hepatocellular Carcinoma
- Durvalumab
- +2 more
-
Hong Kong, Hong KongDepartment of Clinical Oncology, Queen Mary Hospital
Apr 10, 2023
Metastatic Breast Cancer, Metastatic Colorectal Cancer, Metastatic Head Neck Cancer Trial in France (Systemic treatment +
Withdrawn
- Metastatic Breast Cancer
- +2 more
- Systemic treatment + Stereotactic Body Radio-Therapy (SBRT)
- Systemic treatment
-
Albi, France
- +5 more
Jan 28, 2020
Colorectal Cancer, Metastatic Colorectal Cancer, Thymalfasin Trial (Radiation therapy, Thymalfasin)
Withdrawn
- Colorectal Cancer
- +2 more
- Radiation therapy
- Thymalfasin
- (no location specified)
Jun 18, 2019
Metastatic Colorectal Cancer, pMMR, MSS Trial in France (Atezolizumab, Therasphere, XELOX)
Recruiting
- Metastatic Colorectal Cancer
- +4 more
- Atezolizumab
- +3 more
-
Amiens, France
- +18 more
Mar 23, 2022
Cancer Trial in Wiener Neustadt (Particle radiotherapy, Magnetic resonance imaging, Computertomography)
Recruiting
- Cancer
- Particle radiotherapy
- +5 more
-
Wiener Neustadt, Niederösterreich, AustriaEBG MedAustron GmbH
Dec 1, 2022
Small Cell Lung Cancer, Radiotherapy, Thymalfasin Trial (Radiotherapy, Thymalfasin)
Withdrawn
- Small Cell Lung Cancer
- +2 more
- Radiotherapy
- Thymalfasin
- (no location specified)
Mar 19, 2019
NSCLC, Metastatic NSCLC, Radiotherapy Trial (Radiotherapy, Thymalfasin)
Withdrawn
- Non-small Cell Lung Cancer
- +3 more
- Radiotherapy
- Thymalfasin
- (no location specified)
Mar 23, 2019
Immunotherapy And Palliative Radiotherapy Combined In Advanced
Active, not recruiting
- Palliative
- +3 more
- Palliative Radiation Therapy
-
Toronto, Ontario, CanadaPrincess Margaret Hospital
Oct 1, 2021
Pancreas Cancer Trial (Nivolumab, Irreversible electroporation (IRE))
Not yet recruiting
- Pancreas Cancer
- Nivolumab
- Irreversible electroporation (IRE)
- (no location specified)
Jun 27, 2022
Colorectal Liver Metastases Trial in Nanjing (Radiation: High- and Low-dose radiotherapy, PD-1 Inhibitors)
Recruiting
- Colorectal Liver Metastases
- Radiation: High- and Low-dose radiotherapy
- PD-1 Inhibitors
-
Nanjing, Jiangsu, ChinaJiangsu Cancer Hospital
Sep 13, 2023
Metastatic Malignant Solid Tumor Trial in Duarte (Biospecimen Collection, Computed Tomography, Stereotactic Body Radiation
Not yet recruiting
- Metastatic Malignant Solid Neoplasm
- Biospecimen Collection
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 15, 2023
Breast Carcinoma, Metastatic Breast Cancer, Invasive Breast Cancer Trial in Obninsk (Device: Radiation: Diffusing Alpha
Recruiting
- Breast Carcinoma
- +3 more
- Device: Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)
-
Obninsk, Kaluga Region, Russian FederationA. Tsyb Medical Radiological Research Center
Feb 16, 2022
Squamous Cell Carcinoma of the Skin, Malignant Melanoma of Skin, Merkel Cell Carcinoma of Skin Trial in Marlborough (PH-762)
Not yet recruiting
- Squamous Cell Carcinoma of the Skin
- +2 more
-
Marlborough, MassachusettsPhio Pharmaceuticals Corp.
Aug 25, 2023
Breast Cancer Trial in Boston (Atezolizumab, Stereotactic radiosurgery (SRS))
Active, not recruiting
- Breast Cancer
- Atezolizumab
- Stereotactic radiosurgery (SRS)
-
Boston, MassachusettsDana-Farber Cancer Institute
Aug 15, 2022